Josep M. Masana-Cornet
Barcelona, CT 08916, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
A Novel Family of Lysosomotropic Tetracyclic Compounds for Treating Leukemia.
Journal: Cancers
Published: March 01, 2023
Prolactin receptor signaling induces acquisition of chemoresistance and reduces clonogenicity in acute myeloid leukemia.
Journal: Cancer cell international
Published: February 21, 2023
Germ line variants in patients with acute myeloid leukemia without a suspicion of hereditary hematologic malignancy syndrome.
Journal: Blood advances
Published: January 13, 2023
Lysosome-mediated chemoresistance in acute myeloid leukemia.
Journal: Cancer drug resistance (Alhambra, Calif.)
Published: May 18, 2022
Histamine receptor 1 is expressed in leukaemic cells and affects differentiation sensitivity.
Journal: Journal of cellular and molecular medicine
Published: April 22, 2020
Dual lysosomal-mitochondrial targeting by antihistamines to eradicate leukaemic cells.
Journal: EBioMedicine
Published: July 18, 2019
Serotonin receptor type 1B constitutes a therapeutic target for MDS and CMML.
Journal: Scientific reports
Published: April 03, 2018
Inhibition of serotonin receptor type 1 in acute myeloid leukemia impairs leukemia stem cell functionality: a promising novel therapeutic target.
Journal: Leukemia
Published: July 21, 2016
Repositioning of bromocriptine for treatment of acute myeloid leukemia.
Journal: Journal of translational medicine
Published: June 15, 2016
Emetine induces chemosensitivity and reduces clonogenicity of acute myeloid leukemia cells.
Journal: Oncotarget
Published: February 24, 2016
Treatment with G-CSF reduces acute myeloid leukemia blast viability in the presence of bone marrow stroma.
Journal: Cancer cell international
Published: October 16, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026